Status:
COMPLETED
Autologous Chondrocyte Implantation in the Patellofemoral Joint
Lead Sponsor:
Orthopaedic Research Foundation
Collaborating Sponsors:
Genzyme, a Sanofi Company
Conditions:
Chondrosis
Patellar Articular Cartilage Lesions
Eligibility:
All Genders
18-50 years
Brief Summary
The purpose of this study is to measure the outcomes of patients who have articular cartilage lesions in the patellofemoral joint and are treated with the Autologous Chondrocyte Implantation.
Detailed Description
Cartilage restoration, in general, is a relatively new option for the treatment of articular cartilage lesions primarily of the knee. In the initial autologous cultured chondrocyte transplantation (AC...
Eligibility Criteria
Inclusion
- Carticel Implantation of the patella and/or trochlear lesion. Patients who have reached their two-year follow-up date. All patients included in sequential order.
Exclusion
- Patients that have had a microfracture in the knee joint at the same time as Carticel Implantation.
- Patients that have implantable lesions other than the patella and trochlea.
Key Trial Info
Start Date :
January 1 1995
Trial Type :
OBSERVATIONAL
End Date :
August 1 2005
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00212849
Start Date
January 1 1995
End Date
August 1 2005
Last Update
September 21 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orthopaedics Indianapolis
Indianapolis, Indiana, United States, 46237